Segmental differences in rat aorta contraction induced by phenylephrine in aortic rings. 1999

J Asbun-Bojalil, and B Escalante-Acosta, and G Ceballos-Reyes, and M E Ocharán-Hernández, and E F Castillo-Henkel, and C Castillo-Henkel
Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina del Instituto Politécnico Nacional, México, D.F. México.

UI MeSH Term Description Entries
D008297 Male Males
D010656 Phenylephrine An alpha-1 adrenergic agonist used as a mydriatic, nasal decongestant, and cardiotonic agent. (R)-3-Hydroxy-alpha-((methylamino)methyl)benzenemethanol,Metaoxedrin,Metasympatol,Mezaton,Neo-Synephrine,Neosynephrine,Phenylephrine Hydrochloride,Phenylephrine Tannate,Neo Synephrine,Tannate, Phenylephrine
D011448 Prostaglandin Antagonists Compounds that inhibit the action of prostaglandins. Prostaglandin Inhibitors,Antagonists, Prostaglandin,Inhibitors, Prostaglandin,Prostaglandin Antagonist,Prostaglandin Inhibitor,Antagonist, Prostaglandin,Inhibitor, Prostaglandin
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001011 Aorta The main trunk of the systemic arteries. Aortas
D001012 Aorta, Abdominal The aorta from the DIAPHRAGM to the bifurcation into the right and left common iliac arteries. Abdominal Aorta,Abdominal Aortas,Aortas, Abdominal
D001013 Aorta, Thoracic The portion of the descending aorta proceeding from the arch of the aorta and extending to the DIAPHRAGM, eventually connecting to the ABDOMINAL AORTA. Aorta, Ascending,Aorta, Descending,Aortic Arch,Aortic Root,Arch of the Aorta,Descending Aorta,Sinotubular Junction,Ascending Aorta,Thoracic Aorta,Aortic Roots,Arch, Aortic,Ascending Aortas,Junction, Sinotubular,Root, Aortic,Sinotubular Junctions
D013928 Thromboxane A2 An unstable intermediate between the prostaglandin endoperoxides and thromboxane B2. The compound has a bicyclic oxaneoxetane structure. It is a potent inducer of platelet aggregation and causes vasoconstriction. It is the principal component of rabbit aorta contracting substance (RCS). Rabbit Aorta Contracting Substance,A2, Thromboxane
D014662 Vasoconstrictor Agents Drugs used to cause constriction of the blood vessels. Vasoactive Agonist,Vasoactive Agonists,Vasoconstrictor,Vasoconstrictor Agent,Vasoconstrictor Drug,Vasopressor Agent,Vasopressor Agents,Vasoconstrictor Drugs,Vasoconstrictors,Agent, Vasoconstrictor,Agent, Vasopressor,Agents, Vasoconstrictor,Agents, Vasopressor,Agonist, Vasoactive,Agonists, Vasoactive,Drug, Vasoconstrictor,Drugs, Vasoconstrictor

Related Publications

J Asbun-Bojalil, and B Escalante-Acosta, and G Ceballos-Reyes, and M E Ocharán-Hernández, and E F Castillo-Henkel, and C Castillo-Henkel
March 2007, European journal of anaesthesiology,
J Asbun-Bojalil, and B Escalante-Acosta, and G Ceballos-Reyes, and M E Ocharán-Hernández, and E F Castillo-Henkel, and C Castillo-Henkel
January 2021, European journal of pharmacology,
J Asbun-Bojalil, and B Escalante-Acosta, and G Ceballos-Reyes, and M E Ocharán-Hernández, and E F Castillo-Henkel, and C Castillo-Henkel
November 2005, Canadian journal of anaesthesia = Journal canadien d'anesthesie,
J Asbun-Bojalil, and B Escalante-Acosta, and G Ceballos-Reyes, and M E Ocharán-Hernández, and E F Castillo-Henkel, and C Castillo-Henkel
October 1992, Medicine and science in sports and exercise,
J Asbun-Bojalil, and B Escalante-Acosta, and G Ceballos-Reyes, and M E Ocharán-Hernández, and E F Castillo-Henkel, and C Castillo-Henkel
May 1993, Experimental physiology,
J Asbun-Bojalil, and B Escalante-Acosta, and G Ceballos-Reyes, and M E Ocharán-Hernández, and E F Castillo-Henkel, and C Castillo-Henkel
January 2006, The Journal of pharmacology and experimental therapeutics,
J Asbun-Bojalil, and B Escalante-Acosta, and G Ceballos-Reyes, and M E Ocharán-Hernández, and E F Castillo-Henkel, and C Castillo-Henkel
October 1998, Regulatory peptides,
J Asbun-Bojalil, and B Escalante-Acosta, and G Ceballos-Reyes, and M E Ocharán-Hernández, and E F Castillo-Henkel, and C Castillo-Henkel
January 2012, Vascular pharmacology,
J Asbun-Bojalil, and B Escalante-Acosta, and G Ceballos-Reyes, and M E Ocharán-Hernández, and E F Castillo-Henkel, and C Castillo-Henkel
June 2009, Yonsei medical journal,
J Asbun-Bojalil, and B Escalante-Acosta, and G Ceballos-Reyes, and M E Ocharán-Hernández, and E F Castillo-Henkel, and C Castillo-Henkel
January 2002, Acta pharmacologica Sinica,
Copied contents to your clipboard!